However until this approach will become the standard diagnostic test we recommend that NDUFS6 together with other mitochondrial genes (including SCO2 and SURF1) should be included in panels for molecular genetic testing of neuropathies, intellectual disabillity and optic atrophy. This evidence concerns the gene SURF1 and hereditary optic atrophy.